About ModeX Therapeutics
ModeX Therapeutics is a company based in Natick (United States) founded in 2020 was acquired by Opko Health in May 2022.. ModeX Therapeutics offers products and services including MSTAR Platform and Nanoparticle Vaccine Platform. ModeX Therapeutics operates in a competitive market with competitors including Moderna, BeiGene, Adaptive Biotechnologies, Incyte and MorphoSys, among others.
- Headquarter Natick, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Opko Health
(May 23, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ModeX Therapeutics
ModeX Therapeutics offers a comprehensive portfolio of products and services, including MSTAR Platform and Nanoparticle Vaccine Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for creating multispecific biologic molecules to target diseases
Technology for developing nanoparticle-based vaccines against complex diseases
Funding Insights of ModeX Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ModeX Therapeutics
ModeX Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Opko Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Molecular diagnostic products for prostate cancer assessment are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ModeX Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ModeX Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Modex Therapeutics Comparisons
Competitors of ModeX Therapeutics
ModeX Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BeiGene, Adaptive Biotechnologies, Incyte and MorphoSys, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Therapeutic antibodies for cancer and other diseases are developed.
|
|
| domain | founded_year | HQ Location |
Antiviral oral therapeutics are developed for infectious diseases and cancers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Modex Therapeutics
Frequently Asked Questions about ModeX Therapeutics
When was ModeX Therapeutics founded?
ModeX Therapeutics was founded in 2020.
Where is ModeX Therapeutics located?
ModeX Therapeutics is headquartered in Natick, United States. It is registered at Natick, Massachusetts, United States.
What does ModeX Therapeutics do?
ModeX Therapeutics was founded in 2020 and is headquartered in Natick, United States. Focus is placed on biotechnology within the immune therapy sector, where multi-specific antibody platforms are developed for targeting and gene-based delivery using mRNA or DNA vectors. The product pipeline encompasses immunotherapies for cancer as well as treatments for viral diseases including HIV and SARS-CoV-2. Operations center on advancing these technologies for clinical applications.
Who are the top competitors of ModeX Therapeutics?
ModeX Therapeutics's top competitors include Moderna, BeiGene and Adaptive Biotechnologies.
What products or services does ModeX Therapeutics offer?
ModeX Therapeutics offers MSTAR Platform and Nanoparticle Vaccine Platform.
Who are ModeX Therapeutics's investors?
ModeX Therapeutics has 1 investor. Key investors include Opko Health.